Chronic Pelvic Pain SyndromePEMFNCT07867808
Pulsed Electromagnetic Versus Hydrotherapy on Chronic Pelvic Pain
A study testing pulsed electromagnetic field, hydrotherapy and traditional physical therapy program in people with Chronic Pelvic Pain Syndrome, run by Horus University at 1 site in Jordan.
Trial summary
Pulsed electromagnetic field therapy and hydrotherapy are non-invasive treatment modalities that may alleviate chronic pelvic pain through pain modulation, reduction of inflammation, enhancement of circulation, and relaxation of pelvic musculature. Read more about this study
- Who is it for?
- Ages 42 to 52 years, men onlyHealthy volunteers can take part
- Conditions the study is for
- Chronic Pelvic Pain Syndrome
- What is being tested?
- pulsed electromagnetic field, hydrotherapy and traditional physical therapy program
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 300 participants
- Where
- 1 siteJordan
- Study dates
- 20 Jul 2026to 30 Nov 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 42 to 52 years
- Men only
- Healthy volunteers accepted
- Adult
Who may be able to join
- male patients aged 42 - 50 years
- chronic non bacterial prostatitis
- Diagnosis of Chronic Non-Bacterial Prostatitis/Chronic Pelvic Pain Syndrome (NIH Category III) confirmed by a urologist.
- Presence of pelvic, perineal, suprapubic, testicular, penile, or ejaculatory pain for at least 3 months within the previous 6 months.
- Stable medical treatment for at least 4 weeks before enrollment, if receiving medications.
- Ability to understand study procedures and provide written informed consent. Willingness to refrain from initiating new treatments for prostatitis during the study period.
Who cannot join
- Diagnosis of acute bacterial prostatitis
- History of prostate cancer, bladder cancer, or other pelvic malignancy
- Previous prostate surgery within the last 12 months
- Contraindications to hydrotherapy, including: Open wounds, Active skin infections, Uncontrolled epilepsy, Severe cardiac insufficiency
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
About this study
Official title: Effect of Pulsed Electromagnetic Field Versus Hydrotherapy on Chronic Pelvic Pain Syndrome: A Randomized Controlled Trial
Pulsed electromagnetic field therapy and hydrotherapy are non-invasive treatment modalities that may alleviate chronic pelvic pain through pain modulation, reduction of inflammation, enhancement of circulation, and relaxation of pelvic musculature. Both interventions have demonstrated potential benefits in reducing pain severity and improving functional outcomes and quality of life in patients with chronic pelvic pain syndrome, supporting their investigation as therapeutic options in clinical research
Read the detailed description
Chronic pelvic pain syndrome is a multifactorial condition characterized by persistent pelvic pain, functional limitations, and impaired quality of life. Pulsed electromagnetic field therapy (PEMF) and hydrotherapy have been proposed as non-pharmacological interventions to address the underlying mechanisms of chronic pain. PEMF may reduce pain by modulating inflammatory responses, enhancing microcirculation, promoting tissue healing, and influencing neural pain pathways. Hydrotherapy may provide therapeutic benefits through the combined effects of warm water, buoyancy, and hydrostatic pressure, leading to muscle relaxation, reduced pelvic floor tension, improved circulation, and enhanced physical function. Previous clinical investigations have demonstrated favorable effects of both interventions on pain intensity, urinary symptoms, functional status, and quality of life in individuals with chronic pelvic pain conditions. Therefore, the combination of PEMF and hydrotherapy may offer a comprehensive therapeutic approach for managing chronic pelvic pain syndrome and improving patient outcomes
- Conditions
- Chronic Pelvic Pain Syndrome
- Being tested
- pulsed electromagnetic field, hydrotherapy, traditional physical therapy program
- Keywords
- Pulsed Electromagnetic, Hydrotherapy, Chronic non-bacterial prostatitis, pelvic pain
- Medical subject headings
- Pelvic Pain
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
pulsed electromagnetic fieldDevice
Participants allocated to the experimental group will receive pulsed electromagnetic field therapy using a low-frequency PEMF device applied over the suprapubic and perineal regions. Participants will be positioned comfortably in a supine lying position during treatment. The electromagnetic field will be delivered at therapeutic frequencies and intensities according to the manufacturer's recommendations for pain management and soft tissue healing. Each treatment session will last approximately 20-30 minutes, administered three sessions per week for 12 weeks.
hydrotherapyDevice
Participants allocated to the hydrotherapy group will undergo a supervised aquatic exercise program conducted in a therapeutic pool with warm water maintained at 32-34°C. Each session will last approximately 45-60 minutes, three times per week for 12 weeks. The intervention will include gentle warm-up exercises, pelvic mobility exercises, stretching, relaxation techniques, and low-to-moderate intensity aerobic and strengthening activities performed in water.
traditional physical therapy programOther
The intervention will be administered by a licensed physiotherapist and will consist of pelvic floor muscle awareness training, relaxation exercises, diaphragmatic breathing, stretching exercises, and controlled pelvic floor muscle contractions.
Treatment sessions will be conducted three times per week for 12 weeks, with each session lasting approximately 30-45 minutes. Participants will also be instructed to perform a structured home exercise program on non-treatment days
| Study group | Role | What they receive |
|---|---|---|
| Study Group I | Experimental | Pulsed electromagnetic field and traditional program in the form of pelvic floor muscle training Receives: Device: pulsed electromagnetic field; Other: traditional physical therapy program |
| Study Group II | Experimental | hydrotherapy and traditional program in the form of pelvic floor muscle training Receives: Device: hydrotherapy; Other: traditional physical therapy program |
| Control group | Experimental | traditional program in the form of pelvic floor muscle training Receives: Other: traditional physical therapy program |
What is being measured
The primary outcome is the main question the study is designed to answer.
chronic pelvic pain
will be measured by visual analogue scale interpreting pain intensity with minimum score = 0 and maximum score = 10, and lower scores means a better improvement
Measured: 12 weeks
Secondary outcomes (1)
participants quality of life
International consultation on incontinence questionnaire short-form is scored from 0 to 21 points with the lower scores means a better improvement
Measured: 12 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Oct 2026
- Study start20 Jul 2026
- Primary completion30 Oct 2026 (estimated)
- Study completion30 Nov 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Chronic Pelvic Pain SyndromeStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- comparing the effect of pulsed electromagnetic therapy versus hydrotherapy when added with traditional treatment in cases of chronic pelvic pain syndrome
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 300 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Horus University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Mohamed Abd El-Naser, Horus University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07867808
- Sponsor's protocol ID
- IRB#16/7/2025-2026
- Other IDs
- IRB#16/7/2025-2026
- Acronym
- PEMF
- Status last verified
- Oct 2026
- First submitted
- 5 Oct 2026
- Last updated
- 9 Oct 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: not be shared
Study at a glance
From the registry record, last updated by the sponsor on 9 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effect of Pulsed Electromagnetic Field Versus Hydrotherapy on Chronic Pelvic Pain Syndrome: A Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT07867808
- Acronym / sponsor ID
- PEMF / IRB#16/7/2025-2026
- Conditions
- Chronic Pelvic Pain Syndrome
- Keywords
- Pulsed Electromagnetic, Hydrotherapy, Chronic non-bacterial prostatitis, pelvic pain
- Study type
- Interventional
- Recruitment status
- Enrolling by invitation
- Enrolment
- 300 participants (estimated)
- Lead sponsor
- Horus UniversityUniversity, hospital or other
- Study start
- 20 Jul 2026 (actual)
- Primary completion
- 30 Oct 2026 (estimated)
- Study completion
- 30 Nov 2026 (estimated)
- First posted
- 9 Oct 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Pulsed electromagnetic field therapy and hydrotherapy are non-invasive treatment modalities that may alleviate chronic pelvic pain through pain modulation, reduction of inflammation, enhancement of circulation, and relaxation of pelvic musculature. Both interventions have demonstrated potential benefits in reducing pain severity and improving functional outcomes and quality of life in patients with chronic pelvic pain syndrome, supporting their investigation as therapeutic options in clinical research
Detailed description
Chronic pelvic pain syndrome is a multifactorial condition characterized by persistent pelvic pain, functional limitations, and impaired quality of life. Pulsed electromagnetic field therapy (PEMF) and hydrotherapy have been proposed as non-pharmacological interventions to address the underlying mechanisms of chronic pain. PEMF may reduce pain by modulating inflammatory responses, enhancing microcirculation, promoting tissue healing, and influencing neural pain pathways. Hydrotherapy may provide therapeutic benefits through the combined effects of warm water, buoyancy, and hydrostatic pressure, leading to muscle relaxation, reduced pelvic floor tension, improved circulation, and enhanced physical function. Previous clinical investigations have demonstrated favorable effects of both interventions on pain intensity, urinary symptoms, functional status, and quality of life in individuals with chronic pelvic pain conditions. Therefore, the combination of PEMF and hydrotherapy may offer a comprehensive therapeutic approach for managing chronic pelvic pain syndrome and improving patient outcomes
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 3
- Model description
- comparing the effect of pulsed electromagnetic therapy versus hydrotherapy when added with traditional treatment in cases of chronic pelvic pain syndrome
| Arm | Type | Receives |
|---|---|---|
| Study Group I | Experimental | Device: pulsed electromagnetic field, Other: traditional physical therapy programPulsed electromagnetic field and traditional program in the form of pelvic floor muscle training |
| Study Group II | Experimental | Device: hydrotherapy, Other: traditional physical therapy programhydrotherapy and traditional program in the form of pelvic floor muscle training |
| Control group | Experimental | Other: traditional physical therapy programtraditional program in the form of pelvic floor muscle training |
Who may qualify
- Ages
- 42 to 52 years
- Sex
- Male only
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (6 listed)
- male patients aged 42 - 50 years
- chronic non bacterial prostatitis
- Diagnosis of Chronic Non-Bacterial Prostatitis/Chronic Pelvic Pain Syndrome (NIH Category III) confirmed by a urologist.
- Presence of pelvic, perineal, suprapubic, testicular, penile, or ejaculatory pain for at least 3 months within the previous 6 months.
- Stable medical treatment for at least 4 weeks before enrollment, if receiving medications.
Key exclusion criteria (4 listed)
- Diagnosis of acute bacterial prostatitis
- History of prostate cancer, bladder cancer, or other pelvic malignancy
- Previous prostate surgery within the last 12 months
- Contraindications to hydrotherapy, including: Open wounds, Active skin infections, Uncontrolled epilepsy, Severe cardiac insufficiency
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| pulsed electromagnetic fieldParticipants allocated to the experimental group will receive pulsed electromagnetic field therapy using a low-frequency PEMF device applied over the suprapubic and perineal regions. Participants will be positioned comfortably in a supine lying position during treatment. The electromagnetic field will be delivered at therapeutic frequencies and intensities according to the manufacturer's recommendations for pain management and soft tissue healing. Each treatment session will last approximately 20-30 minutes, administered three sessions per week for 12 weeks. | Device | Study Group I |
| hydrotherapyParticipants allocated to the hydrotherapy group will undergo a supervised aquatic exercise program conducted in a therapeutic pool with warm water maintained at 32-34°C. Each session will last approximately 45-60 minutes, three times per week for 12 weeks. The intervention will include gentle warm-up exercises, pelvic mobility exercises, stretching, relaxation techniques, and low-to-moderate intensity aerobic and strengthening activities performed in water. | Device | Study Group II |
| traditional physical therapy programThe intervention will be administered by a licensed physiotherapist and will consist of pelvic floor muscle awareness training, relaxation exercises, diaphragmatic breathing, stretching exercises, and controlled pelvic floor muscle contractions. Treatment sessions will be conducted three times per week for 12 weeks, with each session lasting approximately 30-45 minutes. Participants will also be instructed to perform a structured home exercise program on non-treatment days | Other | Control group, Study Group I, Study Group II |
Primary outcome
chronic pelvic pain
Time frame: 12 weeks
will be measured by visual analogue scale interpreting pain intensity with minimum score = 0 and maximum score = 10, and lower scores means a better improvement
1 secondary outcome
participants quality of life
Time frame: 12 weeks
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Oct 2026.
- Individual participant dataSharing planned: No. not be shared
Related trials for Chronic Pelvic Pain Syndrome
Not yet recruiting
Focused Ultrasound Neuromodulation for Chronic Pain
Chronic Pain, Sickle Cell Disease
Not yet recruiting
Pregabalin for Chronic Pelvic Pain in Women
Chronic Pelvic Pain, Chronic Pelvic Pain Syndrome
Recruiting
Trial of Ovarian Vein and Pelvic Vein Embolization in Women With Chronic Pelvic Pain and Pelvic Varices
Chronic Pelvic Pain Syndrome, Pelvic Pain
Recruiting
EPPIC: Easing Pelvic Pain Interventions Clinical Research Program
Urologic Chronic Pelvic Pain Syndrome (UCPPS), Interstitial Cystitis
RecruitingObservational study
Gene and Molecular Pathways of Ozone Treatment Response in Gynecological Tumor Patients With Chronic Pelvic Pain Secondary to Cancer Treatment
Chronic Pelvic Pain Syndrome (CPPS), Radiation-Induced Disorder
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing pulsed electromagnetic field, hydrotherapy and traditional physical therapy program in people with Chronic Pelvic Pain Syndrome, run by Horus University at 1 site in Jordan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: enrolling by invitation, as of the sponsor's last update on 9 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Jordan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
chronic pelvic pain (time frame: 12 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Oct 2026.